MedPath

ENTYVIO

ENTYVIO

Approved
DIN Number

02497867

Drug Class

Human

Market Date

Jul 8, 2020

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02497867
AIG Number0156530002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AG05 VEDOLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

VEDOLIZUMABActive
Strength: 108 MG / 0.68 ML
Monograph: VEDOLIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.